home.social

#egfr — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #egfr, aggregated by home.social.

  1. The Texas State Plan for #CKD #Chronic #Kidney #Disease Treatment, is 🔥 💪 www.hhs.texas.gov/sites/defaul... Key points: 1) Expands early screening 2) Acknowledges socioeconomic factors in CKD 3) Integrates #proteinuria #EGFR & #genetics 4) School screening for proteinuria & #hypertension

    hhs.texas.gov/sites/default/...

  2. The Texas State Plan for #CKD #Chronic #Kidney #Disease Treatment, is 🔥 💪
    hhs.texas.gov/sites/default/fi
    Key points:
    1) Expands early screening
    2) Acknowledges socioeconomic factors in CKD
    3) Integrates #proteinuria #EGFR & #genetics
    4) School screening for proteinuria & #hypertension

  3. A recently developed ⭐️#cancer #vaccine for dogs⭐️ is showing promising results in clinical trials, which have been running since 2016, and there's hope that some of the benefits of the vaccine could be translated into human cancer treatments.

    More than 300 dogs have been treated with the vaccine to date, and the twelve--month survival rate for canines with certain cancers has been lifted from about 35 percent to 60 percent. Tumors in many of the animals have also shrunk.

    Known officially as the #Canine #EGFR/#HER2 #Peptide #Cancer #Immunotherapeutic, the treatment grew out of studies of autoimmune diseases, where the immune system damages the body's own tissue rather than any invading threats.
    The vaccine is designed to get the immune system to attack cancer instead.

    In many ways tumors are like the targets of autoimmune diseases," says rheumatologist #Mark #Mamula, from the Yale University School of Medicine.

    "Cancer cells are your own tissue and are attacked by the immune system. The difference is we want the immune system to attack a tumor."

    As outlined in a 2021 study by Mamula and colleagues, the treatment gets the immune cells to produce antibody defenses, which attach themselves to tumors and interfere with their growth patterns.

    Specifically, these antibodies hunt down two proteins: 🔸epidermal growth factor receptor 🔸( #EGFR ) and 🔸human epidermal growth factor receptor 2🔸 ( #HER2 ).

    Mutations causing overexpression of these proteins drive uncontrolled cell division in some human and canine cancers.

    sciencealert.com/breakthrough-

  4. A recently developed ⭐️#cancer #vaccine for dogs⭐️ is showing promising results in clinical trials, which have been running since 2016, and there's hope that some of the benefits of the vaccine could be translated into human cancer treatments.

    More than 300 dogs have been treated with the vaccine to date, and the twelve--month survival rate for canines with certain cancers has been lifted from about 35 percent to 60 percent. Tumors in many of the animals have also shrunk.

    Known officially as the #Canine #EGFR/#HER2 #Peptide #Cancer #Immunotherapeutic, the treatment grew out of studies of autoimmune diseases, where the immune system damages the body's own tissue rather than any invading threats.
    The vaccine is designed to get the immune system to attack cancer instead.

    In many ways tumors are like the targets of autoimmune diseases," says rheumatologist #Mark #Mamula, from the Yale University School of Medicine.

    "Cancer cells are your own tissue and are attacked by the immune system. The difference is we want the immune system to attack a tumor."

    As outlined in a 2021 study by Mamula and colleagues, the treatment gets the immune cells to produce antibody defenses, which attach themselves to tumors and interfere with their growth patterns.

    Specifically, these antibodies hunt down two proteins: 🔸epidermal growth factor receptor 🔸( #EGFR ) and 🔸human epidermal growth factor receptor 2🔸 ( #HER2 ).

    Mutations causing overexpression of these proteins drive uncontrolled cell division in some human and canine cancers.

    sciencealert.com/breakthrough-

  5. A recently developed ⭐️#cancer #vaccine for dogs⭐️ is showing promising results in clinical trials, which have been running since 2016, and there's hope that some of the benefits of the vaccine could be translated into human cancer treatments.

    More than 300 dogs have been treated with the vaccine to date, and the twelve--month survival rate for canines with certain cancers has been lifted from about 35 percent to 60 percent. Tumors in many of the animals have also shrunk.

    Known officially as the #Canine #EGFR/#HER2 #Peptide #Cancer #Immunotherapeutic, the treatment grew out of studies of autoimmune diseases, where the immune system damages the body's own tissue rather than any invading threats.
    The vaccine is designed to get the immune system to attack cancer instead.

    In many ways tumors are like the targets of autoimmune diseases," says rheumatologist #Mark #Mamula, from the Yale University School of Medicine.

    "Cancer cells are your own tissue and are attacked by the immune system. The difference is we want the immune system to attack a tumor."

    As outlined in a 2021 study by Mamula and colleagues, the treatment gets the immune cells to produce antibody defenses, which attach themselves to tumors and interfere with their growth patterns.

    Specifically, these antibodies hunt down two proteins: 🔸epidermal growth factor receptor 🔸( #EGFR ) and 🔸human epidermal growth factor receptor 2🔸 ( #HER2 ).

    Mutations causing overexpression of these proteins drive uncontrolled cell division in some human and canine cancers.

    sciencealert.com/breakthrough-

  6. A recently developed ⭐️#cancer #vaccine for dogs⭐️ is showing promising results in clinical trials, which have been running since 2016, and there's hope that some of the benefits of the vaccine could be translated into human cancer treatments.

    More than 300 dogs have been treated with the vaccine to date, and the twelve--month survival rate for canines with certain cancers has been lifted from about 35 percent to 60 percent. Tumors in many of the animals have also shrunk.

    Known officially as the #Canine #EGFR/#HER2 #Peptide #Cancer #Immunotherapeutic, the treatment grew out of studies of autoimmune diseases, where the immune system damages the body's own tissue rather than any invading threats.
    The vaccine is designed to get the immune system to attack cancer instead.

    In many ways tumors are like the targets of autoimmune diseases," says rheumatologist #Mark #Mamula, from the Yale University School of Medicine.

    "Cancer cells are your own tissue and are attacked by the immune system. The difference is we want the immune system to attack a tumor."

    As outlined in a 2021 study by Mamula and colleagues, the treatment gets the immune cells to produce antibody defenses, which attach themselves to tumors and interfere with their growth patterns.

    Specifically, these antibodies hunt down two proteins: 🔸epidermal growth factor receptor 🔸( #EGFR ) and 🔸human epidermal growth factor receptor 2🔸 ( #HER2 ).

    Mutations causing overexpression of these proteins drive uncontrolled cell division in some human and canine cancers.

    sciencealert.com/breakthrough-

  7. A recently developed ⭐️#cancer #vaccine for dogs⭐️ is showing promising results in clinical trials, which have been running since 2016, and there's hope that some of the benefits of the vaccine could be translated into human cancer treatments.

    More than 300 dogs have been treated with the vaccine to date, and the twelve--month survival rate for canines with certain cancers has been lifted from about 35 percent to 60 percent. Tumors in many of the animals have also shrunk.

    Known officially as the #Canine #EGFR/#HER2 #Peptide #Cancer #Immunotherapeutic, the treatment grew out of studies of autoimmune diseases, where the immune system damages the body's own tissue rather than any invading threats.
    The vaccine is designed to get the immune system to attack cancer instead.

    In many ways tumors are like the targets of autoimmune diseases," says rheumatologist #Mark #Mamula, from the Yale University School of Medicine.

    "Cancer cells are your own tissue and are attacked by the immune system. The difference is we want the immune system to attack a tumor."

    As outlined in a 2021 study by Mamula and colleagues, the treatment gets the immune cells to produce antibody defenses, which attach themselves to tumors and interfere with their growth patterns.

    Specifically, these antibodies hunt down two proteins: 🔸epidermal growth factor receptor 🔸( #EGFR ) and 🔸human epidermal growth factor receptor 2🔸 ( #HER2 ).

    Mutations causing overexpression of these proteins drive uncontrolled cell division in some human and canine cancers.

    sciencealert.com/breakthrough-

  8. #EGFR signaling controls directionality of #epithelial multilayer formation upon loss of cell polarity in the #Drosophila follicular epithelium
    Aiguo Tian, Wu-Min Deng et al

    embopress.org/doi/full/10.1525

  9. Next: large database study on age-related normal decline in #eGFR.
    I’m sure Prof. Glassock would like this.

    I forgot to ask if there will be a calculator!

    #DGfN2023

  10. New ChemRxiv preprint! “Pitfalls and considerations in determining the potency and mutant selectivity of covalent #EGFR inhibitors.” Collaboration between our group and AssayQuant Technologies, Inc. #MedicinalChemistry #oncology chemrxiv.org/engage/chemrxiv/a

  11. The EGFR #phosphatase RPTPγ is a #redox-regulated suppressor of promigratory signaling
    Maitreyi Joshi, Philippe Bastiaens et al show that #RPTPγ is coupled to autocatalytic, ligandless #EGFR #phosphorylation by a ROS-mediated toggle-switch, enabling ultrasensitive EGFR activation at the plasma membrane
    embopress.org/doi/10.15252/emb

  12. Modeling & experimental analyses of a Golgi-localized GTPase circuitry that allows cancer cells to achieve self-sufficiency in growth factor signaling ➡️ bit.ly/41DK7Dj
    P Rangamani & P Ghosh, UCSD
    #Gproteins #CellSignaling #EGFR #SystemsBiology

  13. Modeling & experimental analyses of a Golgi-localized GTPase circuitry that allows cancer cells to achieve self-sufficiency in growth factor signaling ➡️ bit.ly/41DK7Dj
    P Rangamani & P Ghosh, UCSD
    #Gproteins #CellSignaling #EGFR #SystemsBiology

  14. Modeling & experimental analyses of a Golgi-localized GTPase circuitry that allows cancer cells to achieve self-sufficiency in growth factor signaling ➡️ bit.ly/41DK7Dj
    P Rangamani & P Ghosh, UCSD
    #Gproteins #CellSignaling #EGFR #SystemsBiology

  15. Modeling & experimental analyses of a Golgi-localized GTPase circuitry that allows cancer cells to achieve self-sufficiency in growth factor signaling ➡️ bit.ly/41DK7Dj
    P Rangamani & P Ghosh, UCSD
    #Gproteins #CellSignaling #EGFR #SystemsBiology

  16. "Using novel humanized IBC mouse models, we discovered that EGFR-targeted therapy remodels the IBC TME by increasing cytotoxic T cells and reducing immunosuppressive regulatory T cells and M2 macrophages. These changes were due to diminishing immunosuppressive chemokine expression regulated by transcription factor EGR1. We also showed that induction of an immunoactive IBC TME by an anti-EGFR antibody improved the antitumor efficacy of an anti–PD-L1 antibody."

    #Immunology #Immunotherapy #EGFR #DrugDevelopment #MonoclonalAntibody

    science.org/doi/10.1126/sciadv